… this is closely related to the cytokine release syndrome (CRS)… and cytokine release occurring
in COVID-19 cases is variable… modulators for the treatment of COVID-19, but the urgency of …

… Compared to the monoclonal antibodies, tocilizumab, sarilumab, and siltuxizumab,
bazedoxifene has additional advantages related to possible effectiveness against COVID-19 entry …

… role of IL-6 in COVID-19, we propose to repurpose tocilizumab to treat severe cases of
COVID-19. … Infection is a common adverse effect associated with immunomodulators such as …

… associated with seriousness of the infection in critical cases [7]. Hypertensive patients are
prone to develop the severe COVID-19 … to be a risk factor in fatal COVID-19 infections as well. …

… the IL-6 response in patients with COVID-19, clarified the pathogenesis of the role of IL-6-mediated
CRS in severe COVID-19, and highlighted the rationale for the use of anti-IL-6 agents …

… Tocilizumab is theorized to treat the CRS that can occur in patients with COVID-19, similar
to its use in CRS secondary to chimeric antigen receptor T-cell therapy. Thus far, reports …

… -associated neurological disturbances in COVID-19 expand previous observations showing
that hyperinflammation is associated with … Cytokine release syndrome is a potentially fatal …

… a cytokine storm is associated with COVID-19 severity and is also a crucial cause of death
from COVID-19… cytokine secretion patterns based on COVID-19 severity are shown in Table 2. …

… Below, we describe four similar COVID-19 serology positive, RT-PCR negative patients
who presented to our New York City Pediatric Emergency Department (PED) approximately 1 …

… that cytokine storms play an important role in severe COVID-19 cases. Therefore, neutralising
key inflammatory factors in cytokine release … The combination of IL-6 and cell-related IL-6R …